Clinical Trial Update: To Describe the Effect of rhLH Supplementation in Women With Hyporesponse to rhFSH After Pituitary Downregulation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is described to evaluate recombinant human LH supplementation in women who are hyporesponsive to recombinant human FSH after pituitary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• rhLH (recombinant human luteinizing hormone)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Infertility | Phase 2 | Status: UNKNOWN